Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Details on Person Harlow, E

Class:Id	Person:77541
_displayName	Harlow, E
_timestamp	2003-10-30 07:46:26
firstname	E
initial	E
surname	Harlow
(author)	[LiteratureReference:77490] New functional activities for the p21 family of CDK inhibitors. [LiteratureReference:141361] Nuclear organization of DNA replication in primary mammalian cells [LiteratureReference:187914] Differential regulation of E2F transactivation by cyclin/cdk2 complexes [LiteratureReference:8862817] p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5 [LiteratureReference:8941977] Identification of G1 kinase activity for cdk6, a novel cyclin D partner [LiteratureReference:9018060] The retinoblastoma protein binds to a family of E2F transcription factors [LiteratureReference:9661049] Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein [LiteratureReference:9928897] Sequences within the conserved cyclin box of human cyclin A are sufficient for binding to and activation of cdc2 kinase
[Change default viewing format]

No pathways have been reviewed or authored by Harlow, E (77541)